ArticleEuropean urology2021

Re: Five-factor Prognostic Model for Survival of Post-platinum Patients with Metastatic Urothelial Carcinoma Receiving PD-L1 Inhibitors.

J Alfred WitjesPubMed ↗Publisher ↗

No numbers read from the abstract.